@article{article, title  = {{Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis.}},

 url = {{}},

 year = {{2003}},

 month = {{3}},

 author = {{Chilcott J and McCabe C and Tappenden P and O'Hagan A and Cooper NJ and Abrams K and Claxton K and Miller DH and Cost Effectiveness of Multiple Sclerosis Therapies Study Group}},

 doi = {{10.1136/bmj.326.7388.522}},

 volume = {{326}},

 journal = {{BMJ}},

 issue = {{7388}},

 pages = {{522}},

 note = {{Accessed on 2024/12/22}}}